INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
Check-out the modus operandi of the emerging spam companies developing mRNA products

Check-out the modus operandi of the emerging spam companies developing mRNA products

Just mugs shots of business people and science munbo jumbo

Hedley Rees's avatar
Hedley Rees
Oct 05, 2023
∙ Paid
10

Share this post

INSIDE PHARMA
INSIDE PHARMA
Check-out the modus operandi of the emerging spam companies developing mRNA products
2
1
Share

First, apologies for for the radio silence

I’ve been travelling over the Welsh border in England for a few days, in Beaconsfield to be exact. Did an interview with

Doc Malik
in his studio on Tuesday, and just done one today for
Debi Evans
and
UK Column’s Substack
, out soon. Hope you forgive the lack of contact.

Leucid Bio

You may remember this post from last week:

Leucid Bio Granted MHRA Approval for Lateral NKG2D CAR T-Cell Therapy LEU011

Hedley Rees
·
September 25, 2023
Leucid Bio Granted MHRA Approval for Lateral NKG2D CAR T-Cell Therapy LEU011

It’s happening folks, our worst nightmares have transpired I’ve been banging on about how MHRA changed its regulations in January 2022 so that advanced therapies (cell & gene therapy and tissue engineering) could be carried out in hospitals. This is a previous post on the topic:

Read full story

This is Leucid

This is the Cell and Gene Therapy Facility that is doing the manufacture for them, under contract

The UK Care Quality Commission gave it a rating of good. Apparently, the CQC is now responsible for inspecting hospitals that are manufacturing gene therapies. Complete nonsense.

Now, take a look at the Executive Team at Leucid (scroll down).

Mainly business, deep science, and finance people, with a few technical folk thrown in. This is the new modus operandi—make up a silly name, directors put mugshots and bios on the website, and the rest of it is filled with scientific mumbo jumbo.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share